Aster Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.35M Buy
+3,629
New +$3.71M 0.93% 12
2025
Q2
Sell
-8,346
Closed -$7.68M 1338
2025
Q1
$7.68M Buy
+8,346
New +$6.94M 1.42% 3
2024
Q4
Sell
-6,456
Closed -$5.72M 1337
2024
Q3
$5.72M Buy
+6,456
New +$5.8M 1.24% 16

Other funds holding LLY

Aster Capital Management's LLY Position: Q2 2026 in Review

Aster Capital Management opened a new position in Eli Lilly (LLY) in Q2 2026: 3,629 shares worth $4.35M. The stake represents 0.93% of the portfolio and ranks #12 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in LLY as recently as Q1 2025.

Aster Capital Management first reported a position in LLY in Q3 2024 and has held it in 3 quarters since. The position peaked at $7.68M in Q1 2025. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Aster Capital Management held 3,629 shares of Eli Lilly worth $4.35M as of Q2 2026.
  • Eli Lilly was a new Aster Capital Management position in Q2 2026.
  • Eli Lilly made up 0.93% of Aster Capital Management's portfolio in Q2 2026, its #12 holding.
  • Aster Capital Management first reported a position in Eli Lilly in Q3 2024 and has held it in 3 quarters since.
  • Aster Capital Management's Eli Lilly position peaked at $7.68M in Q1 2025.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.